Children’s Hospital of Chongqing Medical University, Chongqing, China
Prof. Qiu Li is the doctoral supervisor and former president of Children’s Hospital of Chongqing Medical University, Director of National Children’s Clinical Medical Research Center, Secretary-General of the Standing Committee of the Pediatric Group, Chinese Medical Association. She has been awarded by National Health and Family Planning Commission as an outstanding contribution expert, the first group of Chongqing medical academic leader. She received her Bachelor’s degree in pediatrics at Chongqing Medical University, Master’s degree in clinical medicine at the Third Military Medical University and PhD degree in Pediatric Clinical Immunology at Chongqing Medical University. Her main research areas are pathogenesis of glomerular diseases in children and mechanism of chronic progression of renal damage. She has won the Second Prize of Scientific and Technological progress awarded by Ministry of Education, the First Prize of Scientific and Technological Progress awarded by Chongqing Municipality, and the First Prize of Chongqing Teaching Achievements Award, etc. She has held more than 10 NSFC and other national projects, 21 municipal projects. She has published 160 articles in peer-reviewed journals among which 30 are in SCIE-indexed journals, and more than 19 books. Prof. Li has trained nearly 100 master’s and PhD students.
Molecular Oncology Laboratory, The University of Chicago Medical Center, Chicago, USA
Dr. He completed his medical school education at Chongqing Medical University and received his PhD degree in Molecular Cell Biology from The Pennsylvania State University. Upon completing his postdoctoral training at the Howard Hughes Medical Institute and Johns Hopkins Oncology Center, Dr. He was recruited as a faculty and the Director of Molecular Oncology Laboratory at The University of Chicago Medical Center, where he stays since and is now a tenured faculty member. Dr. He identified C-MYC as the first downstream target of the Wnt/b-catenin pathway in colorectal cancer and was the original developer of the AdEasy system, which has been used by more than 3,000 academic and pharmaceutical laboratories globally. His lab has a broad range of research interests including cancer biology, cell signaling, stem cell biology, cell and gene therapy, and regenerative medicine. He has published over 350 peer-reviewed original articles, reviews, and book chapters, which have been cited more than 44,800 times with an h-index of 91 (Google Scholar). Dr. He is the founding Editor-in-Chief for Genes & Diseases, and serves on the editorial boards of several journals, including Journal of Biological Chemistry, Scientific Reports, Laboratory Investigation, Stem Cell International, Cells, Frontiers in Oncology, and Current Cancer Drug Target.
Institute of Health Data Science, Lanzhou University, Lanzhou, China
Dr. Yaolong Chen is a guideline methodologist at the Evidence Based Medicine Centre of Lanzhou University. He is the Dean of Institute of Health Data Science, Lanzhou University, the Founding Director of Chinese GRADE Centre and Co-Director of WHO Collaborating Centre for Guideline Implementation and Knowledge Translation. He also serves as the Chair of GIN Asia (Guideline International Network), Director of Cochrane Affiliate, Lanzhou University, and Convener of Testing Treatments interactive. He received his Bachelor’s degree in clinical medicine at Lanzhou University, Master’s degree in evidence-based medicine at Chinese Cochrane Centre, and PhD degree in integrative medicine at Lanzhou University. He studied guideline development in McMaster University between September 2010 and March 2011 as a visiting research fellow and worked for the WHO Guidelines Review Committee between September 2013 and March 2014 as a volunteer. Dr. Chen is the Co-Founder and Co-Chair of RIGHT (Reporting Items for Practice Guidelines in Healthcare) working group, and the Co-Founder of Practice Guideline Register Platform (http://www.guidelines-registry.org). He has authored and co-authored more than 500 peer-reviewed articles on evidence-based medicine, GRADE and practice guidelines. He has been invited to give numerous presentations in Cochrane colloquiums, GIN conferences and other national and international symposiums. He was involved in the development of more than 100 national and international practice guidelines over the last ten years.
Children’s Hospital of Chongqing Medical University, China
Dr. Xiaodong Zhao attended Chongqing Medical University since 1988 where he completed medical school and received a Ph.D. degree in Pediatrics in 1998. Since then, he works as a pediatrician in the Division of Nephrology & Immunology, Children’s Hospital of Chongqing Medical University and become the professor since 2006. Upon completing his post-doctoral training at the University of Alabama at Birmingham (2004), Dr. Zhao led his own group focused on the research of Primary Immunodeficiency Disease (PID, also known as Inborn Errors of Immunity). While serving as both pediatrician and scientist, he has led a collaborative group and united colleagues across the country to establish the system of Chinese PID prevention and treatment. And fair contribution has been made by his group to the discovery of Wiskott-Aldrich Syndrome protein (WASp) function in the function of human T/B cell, and in the differentiation and function of multiple immune subsets. His team has also shown great interest in the discovery of novel pathogenic genes in PID diseases and underlying immunological mechanisms. Dr. Zhao has held more than 20 national grants and published over 100 original articles as first or corresponding author. He had also been served as the editor-in-chief of several national textbooks of pediatrics, including Pediatric Immunology.
Janne Estill, PhD, University of Geneva, Switzerland
Ivan Florez, MD, MSc, PhD, University of Antioquia, Colombia
Ziyu Hua, MD, Children's Hospital of Chongqing Medical University, China
Enmei Liu, MD, PhD, Children's Hopsital of Chongqing Medical Univerity, China
Joseph L. Mathew, MD, PhD, Pediatric Pulmonology Division, Department of Pediatrics, PGIMER Chandigarh, India
Xiongzhong Ruan, MD, PhD, University College London, UK
Karen Spruyt, PhD, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France
Yuan Shi, MD, PhD, Children's Hopsital of Chongqing Medical Univerity, China
Jie Tian, MD, PhD, Children's Hopsital of Chongqing Medical Univerity, China
Wenwei Tu, MD, PhD, The University of Hong Kong, China
Xuefei Zhong, MD, M.Sc., Children's Hospital of Chongqing Medical University, China
Daniel Bernstein, MD, Stanford University School of Medicine, USA
Yang Bi, MD, PhD, Children's Hospital of Chongqing Medical University, China
Klas Blomgren, PhD, Karolinska Institutet, Sweden
Jiwang Chen, PhD, University of Illinois at Chicago, USA
Zhifang Dong, PhD, Children's Hospital of Chongqing Medical University, China
Yu He, MD, Children's Hospital of Chongqing Medical University, China
Xupei Huang, MD, PhD, Florida Atlantic University School of Medicine, USA
Chuanju Liu, PhD, New York University Medical Center, USA
Tiewei Lv, MD, PhD, Children's Hospital of Chongqing Medical University, China
Chao Niu, MD, PhD, Children's Hospital of Chongqing Medical University, China
Silin Pan, MD, PhD, Women and Children’s Hospital, Qingdao University, China
Zhijian Qian, PhD, University of Florida School of Medicine, USA
Russell R. Reid, MD, PhD, The University of Chicago Medical Center, USA
Xing Shen, MD, PhD, Affiliated Hospital of Southwest Medical University, China
Yu Shi, PhD, Children's Hospital of Chongqing Medical University, China
Surjit Singh, MD, DCH, Pediatric Allergy Immunology Unit, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
Xiao-Di Tan, MD, UIC Pediatrics, USA
Jun Tang, MD, PhD, Children's Hospital of Chongqing Medical University, China
Zhongbin Tao, MD, PhD, The First Hospital of Lanzhou University, China
Shengde Wu, MD, PhD, Children's Hospital of Chongqing Medical University, China
Xi Yang, PhD, Children's Hospital of Chongqing Medical University, China
Kaiyu Zhou, MD, PhD, West China Second University Hospital, Sichuan University, China
Biyue Zhu, MD, PhD, Children's Hospital of Chongqing Medical University, China
Yupeng Chen, PhD, Tianjin Medical University, China
Umesh Dyamenahalli, M.D, FACC, CMQ, The University of Chicago Medical Center, USA
Narutoshi Hibino, MD, PhD, The University of Chicago Medical Center, USA
Alex Gileles-Hillel, MD, Hadassah-Hebrew University Medical Center, Israel
Yunjie Huang, PhD, Indiana University School of Medicine, Indiana, USA
Hirokazu Kanegane, MD, PhD, Tokyo Medical and Dental University, Japan
Shibani Kanungo, MD, MPH, FAAP, FACMG, Western Michigan University Homer Stryker MD School of Medicine, USA
Hue H. Luu, MD, The University of Chicago Medical Center, USA
Leyla Namazova-Baranova, MD, PhD, Institute of Paediatrics, Federal State Autonomous Institution, Ministry of Health of the Russian, Russia
Anjaparavanda P. Naren, PhD, UC Department of Pediatrics, Cincinnati Children's Hospital, Ohio, USA
Jaime S Rosa Duque, MD, PhD, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China
Yiping Shen, PhD, FACMG, Boston Children's Hospital of Harvard Medical School, USA
Hong-Gang Wang, PhD, Pennsylvannia State University College of Medicine, USA
David Warburton, MD, University of Southern California and Children’s Hospital Los Angeles, USA
Shuo Wei, PhD, University of Delaware, Delaware, USA
Shu Yang, MD, Chengdu University of Traditional Chinese Medicine, China
Aihua Zhang, MD, PhD, Nanjing Medical University, China
Yinglin Xia, PhD, University of Illinois Chicago Medical Center, USA
Liz Ryancoun, PhD
Yu-lung Lau, MBChB, MD, The University of Hong Kong, China
Tao Xu, PhD, CASM, Chinese Academic of Science Member, China
Xiqiang Yang, MD, PhD, Children's Hopsital of Chongqing Medical Univerity, China
Wanshu Zhang, PhD, Wiley